CN104017086A - 一种融合抗菌肽及其制备方法 - Google Patents
一种融合抗菌肽及其制备方法 Download PDFInfo
- Publication number
- CN104017086A CN104017086A CN201410284681.9A CN201410284681A CN104017086A CN 104017086 A CN104017086 A CN 104017086A CN 201410284681 A CN201410284681 A CN 201410284681A CN 104017086 A CN104017086 A CN 104017086A
- Authority
- CN
- China
- Prior art keywords
- antibacterial peptide
- fusion
- peptide
- antibacterial
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003910 polypeptide antibiotic agent Substances 0.000 title claims abstract description 113
- 230000004927 fusion Effects 0.000 title claims abstract description 52
- 238000002360 preparation method Methods 0.000 title claims abstract description 19
- 102000044503 Antimicrobial Peptides Human genes 0.000 title abstract description 13
- 108700042778 Antimicrobial Peptides Proteins 0.000 title abstract description 13
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 20
- USSYUMHVHQSYNA-SLDJZXPVSA-N indolicidin Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(N)=O)CC1=CNC2=CC=CC=C12 USSYUMHVHQSYNA-SLDJZXPVSA-N 0.000 claims abstract description 10
- 108020004705 Codon Proteins 0.000 claims abstract description 5
- 230000000844 anti-bacterial effect Effects 0.000 claims description 20
- 108020004511 Recombinant DNA Proteins 0.000 claims description 14
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 14
- 238000013461 design Methods 0.000 claims description 10
- 239000013604 expression vector Substances 0.000 claims description 9
- 229920001184 polypeptide Polymers 0.000 claims description 9
- 230000036039 immunity Effects 0.000 claims description 7
- 239000000654 additive Substances 0.000 claims description 6
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 4
- 239000003814 drug Substances 0.000 claims description 4
- 235000001014 amino acid Nutrition 0.000 claims description 3
- 150000001413 amino acids Chemical class 0.000 claims description 3
- 230000000845 anti-microbial effect Effects 0.000 abstract description 12
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract description 6
- 244000144972 livestock Species 0.000 abstract description 6
- 241000588724 Escherichia coli Species 0.000 abstract description 5
- 238000000746 purification Methods 0.000 abstract description 2
- 241000283690 Bos taurus Species 0.000 abstract 1
- 239000003674 animal food additive Substances 0.000 abstract 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 229940088710 antibiotic agent Drugs 0.000 abstract 1
- 239000000047 product Substances 0.000 description 11
- 241000894006 Bacteria Species 0.000 description 10
- 239000003153 chemical reaction reagent Substances 0.000 description 7
- 230000001900 immune effect Effects 0.000 description 7
- 238000000034 method Methods 0.000 description 6
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 5
- 230000003321 amplification Effects 0.000 description 5
- 238000003199 nucleic acid amplification method Methods 0.000 description 5
- 241000191967 Staphylococcus aureus Species 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 230000000968 intestinal effect Effects 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 238000012827 research and development Methods 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 230000003385 bacteriostatic effect Effects 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 239000013598 vector Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 208000030507 AIDS Diseases 0.000 description 2
- 102000014133 Antimicrobial Cationic Peptides Human genes 0.000 description 2
- 108010050820 Antimicrobial Cationic Peptides Proteins 0.000 description 2
- 206010010356 Congenital anomaly Diseases 0.000 description 2
- 108020004414 DNA Proteins 0.000 description 2
- 108010042407 Endonucleases Proteins 0.000 description 2
- 102000004533 Endonucleases Human genes 0.000 description 2
- 102100029727 Enteropeptidase Human genes 0.000 description 2
- 108010013369 Enteropeptidase Proteins 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000000137 annealing Methods 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000012295 chemical reaction liquid Substances 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 230000001186 cumulative effect Effects 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 238000013467 fragmentation Methods 0.000 description 2
- 238000006062 fragmentation reaction Methods 0.000 description 2
- 230000000855 fungicidal effect Effects 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- 150000002460 imidazoles Chemical class 0.000 description 2
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 210000004493 neutrocyte Anatomy 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 230000001131 transforming effect Effects 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- 108700010070 Codon Usage Proteins 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000012969 defense response to bacterium Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000005868 electrolysis reaction Methods 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000012407 engineering method Methods 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000008717 functional decline Effects 0.000 description 1
- 230000002070 germicidal effect Effects 0.000 description 1
- 230000006801 homologous recombination Effects 0.000 description 1
- 238000002744 homologous recombination Methods 0.000 description 1
- 125000001165 hydrophobic group Chemical group 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 238000003259 recombinant expression Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- 235000017103 tryptophane Nutrition 0.000 description 1
- 150000003654 tryptophanes Chemical class 0.000 description 1
- 238000002525 ultrasonication Methods 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Landscapes
- Peptides Or Proteins (AREA)
- Fodder In General (AREA)
Abstract
Description
引物编号 | 序列 |
P1-SEQ ID4 | 5’-agggtaccgacgacgacgacaaggccggtctgctgtctcgtctgcgtgacttcctgtctg-3’ |
P2-SEQ ID5 | 5’-gaccgatacgttcgattttttcacccagacgacgaccacggtcagacaggaagtcac-3’ |
P3-SEQ ID6 | 5’-atcgaacgtatcggtcagaaaatcaaagacctgtctgaattcttccagtctatcctg-3’ |
P4-SEQ ID7 | 5’-gtctcgagttaacgacgccaccacggccaccacggccatttccacggcaggatagactgg-3’ |
抗菌肽 | 大肠杆菌MIC(μg/L) | 金黄色葡萄球菌MIC(μg/L) |
融合抗菌肽 | 2-8 | 0.5-2 |
PAMP37 | 8-32 | 0.5-2 |
indolicidin | 4-16 | 1-4 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410284681.9A CN104017086B (zh) | 2014-06-24 | 2014-06-24 | 一种融合抗菌肽及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410284681.9A CN104017086B (zh) | 2014-06-24 | 2014-06-24 | 一种融合抗菌肽及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104017086A true CN104017086A (zh) | 2014-09-03 |
CN104017086B CN104017086B (zh) | 2016-03-09 |
Family
ID=51434120
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410284681.9A Expired - Fee Related CN104017086B (zh) | 2014-06-24 | 2014-06-24 | 一种融合抗菌肽及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104017086B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106432513A (zh) * | 2016-11-29 | 2017-02-22 | 东北农业大学 | 一种高效杂交抗菌肽li及其制备方法和应用 |
CN114196631A (zh) * | 2020-09-02 | 2022-03-18 | 江苏申琅生物科技有限公司 | 一种抗菌功能多肽及其制备方法和应用 |
CN115947815A (zh) * | 2022-10-10 | 2023-04-11 | 天津科技大学 | 一种重组抗菌肽pmap-37及其制备方法和应用 |
CN115960197A (zh) * | 2022-11-14 | 2023-04-14 | 北京大北农科技集团股份有限公司 | 猪源抗菌肽pamp-37-bt3及其应用 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1896107A (zh) * | 2006-06-13 | 2007-01-17 | 南京农业大学 | 类天蚕素a-马盖宁杂合基因工程抗菌肽 |
CN101063101A (zh) * | 2006-12-28 | 2007-10-31 | 中国科学院亚热带农业生态研究所 | 一种牛乳铁蛋白工程菌及抗菌肽牛乳铁蛋白素的制备方法 |
CN101509007A (zh) * | 2008-12-10 | 2009-08-19 | 东北农业大学 | LfcinB15-Mag12编码基因的合成及在大肠杆菌中表达的方法 |
CN101717737A (zh) * | 2009-12-11 | 2010-06-02 | 中国科学院亚热带农业生态研究所 | 抗菌肽buforinⅡ和猪INF-α融合表达毕赤酵母菌及制备方法和应用 |
CN102532325A (zh) * | 2011-02-25 | 2012-07-04 | 山东省科学院中日友好生物技术研究中心 | 用羟胺切割法制备天蚕素AD和蛙Buforin II融合抗菌肽及其用途 |
CN103435701A (zh) * | 2013-07-24 | 2013-12-11 | 山西农业大学 | 猪抗菌肽cystatin11融合蛋白及其编码基因与应用 |
-
2014
- 2014-06-24 CN CN201410284681.9A patent/CN104017086B/zh not_active Expired - Fee Related
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1896107A (zh) * | 2006-06-13 | 2007-01-17 | 南京农业大学 | 类天蚕素a-马盖宁杂合基因工程抗菌肽 |
CN101063101A (zh) * | 2006-12-28 | 2007-10-31 | 中国科学院亚热带农业生态研究所 | 一种牛乳铁蛋白工程菌及抗菌肽牛乳铁蛋白素的制备方法 |
CN101509007A (zh) * | 2008-12-10 | 2009-08-19 | 东北农业大学 | LfcinB15-Mag12编码基因的合成及在大肠杆菌中表达的方法 |
CN101717737A (zh) * | 2009-12-11 | 2010-06-02 | 中国科学院亚热带农业生态研究所 | 抗菌肽buforinⅡ和猪INF-α融合表达毕赤酵母菌及制备方法和应用 |
CN102532325A (zh) * | 2011-02-25 | 2012-07-04 | 山东省科学院中日友好生物技术研究中心 | 用羟胺切割法制备天蚕素AD和蛙Buforin II融合抗菌肽及其用途 |
CN103435701A (zh) * | 2013-07-24 | 2013-12-11 | 山西农业大学 | 猪抗菌肽cystatin11融合蛋白及其编码基因与应用 |
Non-Patent Citations (3)
Title |
---|
SELSTED ME等: "indolicidin=antimicrobial peptide [cattle, neutrophils[Bos taurus]", 《GENBANK:AAB21494.1》 * |
TOSSI A等: "RecName: Full=Antibacterial peptide PMAP-37;antibacterial peptide 37; Flags: Precursor", 《UNIPROTKB/SWISS-PROT》 * |
黎观红等: "抗菌肽的抗菌作用及其机制", 《动物营养学报》 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106432513A (zh) * | 2016-11-29 | 2017-02-22 | 东北农业大学 | 一种高效杂交抗菌肽li及其制备方法和应用 |
CN114196631A (zh) * | 2020-09-02 | 2022-03-18 | 江苏申琅生物科技有限公司 | 一种抗菌功能多肽及其制备方法和应用 |
CN115947815A (zh) * | 2022-10-10 | 2023-04-11 | 天津科技大学 | 一种重组抗菌肽pmap-37及其制备方法和应用 |
CN115960197A (zh) * | 2022-11-14 | 2023-04-14 | 北京大北农科技集团股份有限公司 | 猪源抗菌肽pamp-37-bt3及其应用 |
CN115960197B (zh) * | 2022-11-14 | 2023-06-30 | 北京大北农科技集团股份有限公司 | 猪源抗菌肽pamp-37-bt3及其应用 |
Also Published As
Publication number | Publication date |
---|---|
CN104017086B (zh) | 2016-03-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104017087B (zh) | 一种猪源抗菌肽及其制备方法 | |
Berne et al. | Aegerolysins: structure, function, and putative biological role | |
CN104017086B (zh) | 一种融合抗菌肽及其制备方法 | |
Boman | Peptide antibiotics: holy or heretic grails of innate immunity? | |
CN105061603B (zh) | 抗菌肽-溶菌酶融合蛋白的制备方法及其应用 | |
CN101932595A (zh) | 噬菌体φmru多核苷酸和多肽及其应用 | |
CN1878789A (zh) | 人凯萨林菌素抗微生物肽 | |
CN104151414B (zh) | 拟穴青蟹抗菌肽SpHyastatin的制备方法与应用 | |
CN104017085A (zh) | Pamp37-pr39融合抗菌肽及其制备方法 | |
Wu et al. | Purification and characterization of recombinant human lysozyme from eggs of transgenic chickens | |
CN101948839B (zh) | 一种合浦珠母贝抗菌肽基因及应用 | |
CN103621795A (zh) | 一种杂合抗菌肽作为饲料添加剂的应用 | |
CN101182360A (zh) | 一种具有抗菌功能的融合蛋白及其应用 | |
CN103833839A (zh) | C型凝集素及其制备方法和应用 | |
CN107475222B (zh) | 基因工程改造的耐热人溶菌酶 | |
CN104263709A (zh) | 鸡蛋清溶菌酶及其制备方法 | |
CN103641901A (zh) | 一种抗菌肽 | |
CN103194442B (zh) | 新型多肽、水解抗菌肽及其制备方法 | |
KR102004153B1 (ko) | 갯지렁이 유래의 신규한 더로마신 펩티드 및 이의 용도 | |
CN106632692A (zh) | 抗菌肽融合蛋白及其制备方法和应用 | |
CN102260325B (zh) | 抗菌肽nx-16及其制备方法与应用 | |
CN102276729A (zh) | 抗菌肽lf-th及其大肠杆菌重组制备方法 | |
Wang et al. | Isolation of a novel leguminous lysozyme and study on the antifungal activity | |
CN102094024A (zh) | 一种小菜蛾天蚕素基因、编码的蛋白、相应的表达***和应用 | |
CN102242092A (zh) | 一种家蚕肠道益生菌的分离鉴定及其酶基因的克隆与表达 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: KEMEI BORUI TECHNOLOGY (BEIJING) CO., LTD. Free format text: FORMER OWNER: REN JIANTING Effective date: 20150320 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20150320 Address after: 100085 No. 1, building 5, building ten, No. 8, 805 street, Beijing, Haidian District Applicant after: Kemei Borui Technology (Beijing) Co.,Ltd. Address before: 100085 splendid international ten, 5-805 street, Beijing, Haidian District Applicant before: Ren Jianting |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160309 Termination date: 20190624 |